Key result
Vascular calcification in CKD drives CV risk, representing a crucial therapeutic target.
Cardiovascular (CV) disease remains an important cause of morbidity and mortality for patients with chronic kidney disease (CKD). Although clustering of traditional risk factors with CKD is well recognized, kidney-specific mechanisms are believed to drive the disproportionate burden of CV disease. One perturbation that is frequently observed at high rates in patients with CKD is vascular calcification, which may be a central mediator for an array of CV sequelae. This review summarizes the pathophysiological bases of intimal and medial vascular calcification in CKD, current strategies for diagnosis and management, and posits vascular calcification as a risk marker and therapeutic target.
No takes yet. Share an insight, caveat, or question.
Nelson et al. (2020) conducted a review in Chronic kidney disease and cardiovascular disease. Vascular calcification diagnosis and management was evaluated. Vascular calcification in chronic kidney disease serves as a central mediator for cardiovascular sequelae and represents both a key clinical risk marker and a therapeutic target.
Synapse has enriched 5 related papers. Consider them for comparative context: